CSC
THRD

Caldwell Sutter Capital’s Third Harmonic Bio THRD Stock Holding History

Caldwell Sutter Capital’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
1,000
– – ﹤0.01% 900
2025
Q4 		$0 Hold
1,000
– – ﹤0.01% 908
2025
Q3 		$0 Buy
+1,000
New +$5.43K ﹤0.01% 890

Other funds holding THRD

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Caldwell Sutter Capital's THRD Position: Q1 2026 in Review

Caldwell Sutter Capital held its Third Harmonic Bio (THRD) position steady in Q1 2026 at 1,000 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #900.

Caldwell Sutter Capital first reported a position in THRD in Q3 2025 and has held it in 3 quarters since. 4 funds tracked by Wall St. Rank hold THRD as of Q1 2026.

  • Caldwell Sutter Capital held 1,000 shares of Third Harmonic Bio worth $0 as of Q1 2026.
  • Caldwell Sutter Capital left its Third Harmonic Bio share count unchanged in Q1 2026.
  • Third Harmonic Bio made up ﹤0.01% of Caldwell Sutter Capital's portfolio in Q1 2026, its #900 holding.
  • Caldwell Sutter Capital first reported a position in Third Harmonic Bio in Q3 2025 and has held it in 3 quarters since.
  • 4 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q1 2026.

Based on Caldwell Sutter Capital's 13F filing for Q1 2026, filed 6 May 2026.